.
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.

.
.
it also provides 85 per cent accurate prediction results than current methods..
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done..